|
|
 | | | |
- close
- close
- close
- close
Solta Medical Inc (SLTM) |
QUOTE AND NEWS
Benzinga
May 2
Comment
In a company update issued earlier today, Cantor Fitzgerald L.P. reiterated its Buy rating for Solta Medical, Inc. (NASDAQ: SLTM) and slightly raised its price target from $4.00 to $5.00, related to the early success of the company's new Liposonix...
StreetInsider.com
May 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Solta+Medical%2C+Inc.+%28SLTM%29+Tops+Q1+EPS+by+4c%3B+Guides+In-line+for+FY+Revenues/7391356.html for the full story.
StreetInsider.com
May 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Solta+Medical+%28SLTM%29+Files+%2475M+Mixed+Shelf/7390792.html for the full story.
PR Newswire
May 1
Comment
HAYWARD, Calif., May 1, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced results for the first quarter ended March 31, 2012. Revenue for the first quarter was $32.5 million, an
PR Newswire
Apr 19
Comment
HAYWARD, Calif., April 19, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, today announced the results of a first-of-its-kind, IRB-approved clinical
PR Newswire
Apr 17
Comment
HAYWARD, Calif., April 17, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today confirmed its plan to release the Company's financial results for the first quarter ended March 31, 2012,
StreetInsider.com
Apr 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Solta+Medical+%28SLTM%29+Unveils+Next-Gen+Liposonix+System/7312939.html for the full story.
PR Newswire
Apr 2
Comment
HAYWARD, Calif., April 2, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, introduced the second generation Liposonix
Benzinga
Mar 12
Comment
Morgan Keegan raises its rating on Solta Medical (NASDAQ: SLTM) to Outperform from Market Perform and raises its price target by 25 cents to $3.75 a share on positive field checks on LipoSonix.
Morgan Keegan says, "We recently surveyed several...
Benzinga
Mar 7
Comment
Solta Medical, Inc. (NASDAQ: SLTM) today provided an update on the launch of the second generation Liposonix non-invasive fat reduction system recently approved by the FDA.
A majority of the Company's approximately twenty key opinion leaders...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
